Interestingly, although they had a similar proportion of total tumor F4/80+ macrophages, mice treated with the STAT3 inhibitor exhibited an increase in in the proportion of tumor CD146+ macrophages compared with that in control mice (Fig. 3O). This evidence concerns the gene STAT3 and neoplasm.